Adaptive Biotechnologies Corp — Form D/A

Adaptive Biotechnologies Corp of SEATTLE, WA, a company, filed a Form D amendment with the SEC on 2014-08-04. The offering totals $107.0M, of which $107.0M was reported sold. Industry: Biotechnology.

Offering

Filed: 2014-08-04
Form: D/A
Accession: 0001478320-14-000002
Industry: Biotechnology
Exemptions: 06b
Total offering: $107.0M
Amount sold: $107.0M
Investors: 6
Date of first sale: 2014-04-04
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-215643

Issuer

Name: Adaptive Biotechnologies Corp
CIK: 0001478320
Entity type: Corporation
Jurisdiction: WASHINGTON
Incorporated: 2009
Address: 1551 EASTLAKE AVENUE EAST SUITE 200, SEATTLE, WA, 98102
Phone: 206-659-0067

Officers, directors & promoters (18)

Name	Role	Location
Chris Carlson	Executive Officer	Sioux Falls, SD
Harlan Robins	Executive Officer	Seattle, WA
Harlan Robins	Director	Seattle, WA
Chad Robins	Director	Seattle, WA
Chad Robins	Executive Officer	Seattle, WA
ARNOLD LEVINE	Director	Durham, NC
Rob Rosen	Director	Washington, DC
Peter Neupert	Director	RALEIGH, NC
Tom Willis	Director	South San Francisco, CA
Lee Huntsman	Director	Seattle, WA
Craig Weissman	Director	SAN FRANCISCO, CA
Andris Zoltners	Director	SEATTLE, WA
Kathleen Determann	Executive Officer	SEATTLE, WA
Rob Hershberg	Director	SEATTLE, WA
Dean Schorno	Executive Officer	SEATTLE, WA
John Stuelpnagel	Director	SEATTLE, WA
Chad Cohen	Director	SEATTLE, WA
Andy Zoltners	Director	Seattle, WA

Other filings by this issuer (8)

Filed	Form	Offering	Sold
2015-05-11	D	$195.1M	$195.1M
2015-01-22	D	$93.8M	$93.8M
2015-01-21	D	$95.7M	$95.7M
2014-04-15	D	$105.0M	$105.0M
2013-07-12	D	$20.0M	$5.0M
2012-06-21	D	$5.0M	$2.6M
2011-06-02	D	$7.5M	$5.8M
2009-12-28	D	$5.0M	$4.0M

More